Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Aurobindo Pharma Acquires Khandelwal Labs’ Non-Cancer Portfolio for ₹325 Crore.

by Team Small News | Jan 12, 2026 | Aurobindo Pharma, Pharma

Aurobindo Pharma, a leading Indian pharmaceutical company, has acquired the non-oncology business of Khandelwal Laboratories for ₹325 crore. The acquisition is a strategic move by Aurobindo Pharma to expand its product portfolio and strengthen its position in the...

Mylan and Aurobindo Pharma must defend against allegations of colluding to fix prices for generic drugs.

by Team Small News | Jan 10, 2026 | Aurobindo Pharma, Pharma

A federal judge in Connecticut has rejected a request by Mylan Pharmaceuticals and Aurobindo Pharma USA to dismiss antitrust litigation against them. The judge ruled that a coalition of states has presented sufficient evidence to raise a genuine dispute about whether...

Aurobindo Pharma Pushes Back Deadline to Purchase 26% Stake in Swarnaakshu Solar

by Team Small News | Jan 4, 2026 | Aurobindo Pharma, Pharma

Aurobindo Pharma has extended the timeline to acquire a 26% stake in Swarnaakshu Solar, a solar power company. The acquisition is part of Aurobindo Pharma’s strategy to diversify its business and invest in renewable energy. The company had initially planned to...

Will Aurobindo Pharma Limited’s New Product Launches Drive Revenue Growth in YEAR – Quarterly Earnings Analysis & Profit Outlook on earlytimes.in

by Team Small News | Dec 13, 2025 | Aurobindo Pharma, Pharma

Aurobindo Pharma Limited, a leading pharmaceutical company, is expected to witness a significant boost in revenue due to the launch of new products. The company has been consistently expanding its product portfolio, and the latest launches are anticipated to...

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress